VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
UTI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
UTIUniversal Technical Institute, Inc.
$20.42$1.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksUTIBalance Sheet

Universal Technical Institute, Inc. (UTI) Balance Sheet

26Y historyFree accessUpdated daily

Total assets grew 21.2% year-over-year to $897.9M, but debt rose to $359.5M (D/E of 1.04) and net PPE now represents 58.0% of assets, indicating a capital-intensive expansion funded by leverage.

Income StatementBalance SheetCash FlowRatios

UTI Balance Sheet

Annual statement

UTI Balance Sheet

Universal Technical Institute, Inc. (UTI) balance sheet — 26-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMSep'25Sep'24Sep'23Sep'22Sep'21Sep'20Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09Sep'08Sep'07Sep'06Sep'05Sep'04Sep'03Sep'02Sep'01Sep'00
Total Current Assets258.08M246.63M221.95M204.99M135.95M183.39M180.18M118.1M116.8M146.83M161.95M108.06M127.53M133.35M134.98M133.47M115.43M114.17M117.62M103.13M70.27M103.7M77.13M31.82M29.28M16.48M21.05M
Cash & Short-Term Investments170.12M169.15M161.9M151.55M95.37M133.72M114.86M65.44M58.1M97.92M120.74M57.52M84.89M93.19M97.12M103.72M77.5M81.34M80.88M75.59M41.43M52.05M42.6M8.93M13.55M3.35M3.33M
Cash Only130.06M127.36M161.9M151.55M66.45M133.72M76.8M65.44M58.1M50.14M119.05M29.44M38.98M35.66M45.66M53.67M48.97M56.2M80.88M75.59M41.43M52.05M42.6M8.93M13.55M3.35M3.33M
Short-Term Investments40.06M41.78M0028.92M038.05M0047.78M1.69M28.09M45.91M57.53M51.45M50.05M28.53M25.14M000000000
Accounts Receivable56.53M52.67M37.3M31.15M22.09M22.69M40.59M23.16M26.29M15.2M15.25M22.41M12.12M11.41M14.91M11.21M19.25M14.89M20.22M14.5M16.7M21.24M20.12M19.86M12.53M00
Days Sales Outstanding21.9223.0118.5818.7219.2524.7149.2725.530.2717.1116.0422.5511.6910.9513.169.0516.1214.8321.4914.9817.5724.9528.7936.8831.67--
Inventory00009.68M0022.17M24.38M-40.02M0000000000014.21M00000
Days Inventory Outstanding----17.05--45.3748.73------------35.77-----
Other Current Assets13.97M12.29M10.81M12.87M2.67M20.32M18.61M22.44M22.08M24.22M5.96M10.36M14.01M23M8.08M8.28M8.84M7.45M7.95M13.04M12.14M7.25M11.18M0013.12M17.73M
Total Non-Current Assets639.78M579.51M522.62M535.7M416.96M329.18M261.8M152.42M165.48M127.28M135.21M166.25M160.54M146.12M133.17M132.11M127.07M109.19M91.76M129.69M141.89M96.91M59.19M52.28M47.61M46.61M47.79M
Property, Plant & Equipment520.77M464.71M423.57M443M346.33M281.13M217.41M104.13M114.85M106.66M114.03M124.14M106.93M103.07M91.94M100.38M99.04M81.17M68.26M104.59M117.3M74.42M36.92M27.45M23.67M00
Fixed Asset Turnover1.81x1.80x1.73x1.37x1.21x1.19x1.38x3.18x2.76x3.04x3.04x2.92x3.54x3.69x4.50x4.50x4.40x4.52x5.03x3.38x2.96x4.18x6.91x7.16x6.10x--
Goodwill28.46M28.46M28.46M28.46M16.86M8.22M8.22M8.22M8.22M9.01M9.01M8.22M20.58M20.58M20.58M20.58M20.58M20.58M20.58M20.58M20.58M20.58M20.58M020.58M00
Intangible Assets25.54M17.35M18.23M18.98M14.21M124K0000000000000000020.58M000
Long-Term Investments195.5M58.1M43.5M30.67M2.07M35.21M32.1M34.19M35.4M4.11M4.04M1.72M11.26M4.19M4.53M5.83M3.6M3.81M-5.95M-5.66M-4.72M-7.05M-785K0000
Other Non-Current Assets17.26M6.59M5.3M10.82M34.12M-43.65M-40.95M-7.18M3.43M11.61M12.17M11.91M9.85M9.44M10.55M-2.51M-4.99M-3.82M2.92M4.51M4.01M1.91M1.68M4.25M3.36M46.61M47.79M
Total Assets897.86M826.14M744.58M740.68M552.91M512.57M441.98M270.53M282.28M274.1M297.16M274.3M288.07M279.46M268.16M265.59M242.5M223.35M209.38M232.82M212.16M200.61M136.32M84.1M76.89M63.09M68.84M
Asset Turnover1.04x1.01x0.98x0.82x0.76x0.65x0.68x1.23x1.12x1.18x1.17x1.32x1.31x1.36x1.54x1.70x1.80x1.64x1.64x1.52x1.64x1.55x1.87x2.34x1.88x1.74x1.34x
Asset Growth %61.09%10.95%0.53%33.96%7.87%15.97%63.38%-4.16%2.98%-7.76%8.33%-4.78%3.08%4.22%0.97%9.52%8.57%6.68%-10.07%9.74%5.76%47.16%62.09%9.38%21.87%-8.37%-
Total Current Liabilities198.29M229.67M204.96M184.7M137.72M132.72M121.64M96.84M92.46M86.39M94.56M96.49M102.33M92.36M99.44M104.7M122.31M101.55M86.6M95.88M96.28M89.88M70.52M61.06M43.85M00
Accounts Payable105.76M39.12M26.27M14.44M21.75M13.7M12.47M10.03M8.76M9.52M11.8M14.5M12.99M13.76M8.25M10.19M9.15M47.28M37.99M6.08M6.26M9.77M32.82M25M000
Days Payables Outstanding58.3433.9524.9415.9838.329.9829.1920.5417.5119.1822.1727.2223.725.1714.216.6415.7189.1874.311.9213.1824.58102.6198.73---
Short-Term Debt2.99M2.87M2.7M2.52M1.11M876K129K000000000000006K37K3.86M3.02M00
Deferred Revenue (Current)324.86M91.53M92.54M85.74M54.22M57.65M40.69M42.89M38.24M41.34M44.49M44.69M46.37M46.89M52.56M61.39M63.28M48.17M44.7M49.39M49.48M42.84M34.52M25.69M000
Other Current Liabilities4M57.67M39.31M40.35M19.25M31.94M16.63M20.14M22.13M19.82M14.85M17.84M15.45M14.78M13.51M12.73M35.92M25K44K416K747K4.5M288K2.98M20.69M00
Current Ratio1.30x1.07x1.08x1.11x0.99x1.38x1.48x1.22x1.26x1.70x1.71x1.12x1.25x1.44x1.36x1.27x0.94x1.12x1.36x1.08x0.73x1.15x1.09x0.52x0.67x--
Quick Ratio1.30x1.07x1.08x1.11x0.92x1.38x1.48x0.99x1.00x2.16x1.71x1.12x1.25x1.44x1.36x1.27x0.94x1.12x1.36x1.08x0.73x1.00x1.09x0.52x0.67x--
Cash Conversion Cycle-36.42----1.99--50.3461.49------------36.14-----
Total Non-Current Liabilities355.26M268.36M279.38M330.02M199.79M191.32M143.82M59.39M63.17M61.94M65.98M64.33M52.54M48.33M22.63M18.78M11.79M15.11M14.58M12.44M12.98M14.99M10.78M106.19M129.19M00
Long-Term Debt157.04M84.23M123.01M159.6M66.42M29.85M131K0000000000000006K28.01M57.89M00
Capital Lease Obligations696.07M174.84M146.83M165.03M129.3M153.23M134.09M39.16M40.72M42.03M43.14M44.05M32.48M00000000000000
Deferred Tax Liabilities16.57M4.14M4.7M663K51.39M674K674K329K329K3.14M3.14M00002.44M933K3.09M2.91M2.02M2.9M7.62M3.05M0000
Other Non-Current Liabilities9.45M5.14M4.85M4.73M4.07M7.57M8.93M19.9M22.13M16.76M19.7M20.28M20.06M48.33M22.63M4.53M5.24M12.02M11.68M10.41M10.08M7.37M7.71M78.18M71.3M00
Total Liabilities553.56M498.03M484.34M514.72M337.51M324.04M265.46M156.24M155.63M148.33M160.54M160.83M154.88M140.69M122.07M123.47M134.11M116.65M101.19M108.32M109.26M104.88M81.29M167.25M173.04M166.06M160.92M
Total Debt359.47M278.9M294.75M349.62M209.8M198.03M157.75M40.72M42.03M43.14M44.05M44.79M37.71M000000006K43K31.87M60.9M00
Net Debt229.41M151.54M132.84M198.08M143.35M64.31M80.95M-24.73M-16.07M-7M-74.99M15.35M-1.27M-35.66M-45.66M-53.67M-48.97M-56.2M-80.88M-75.59M-41.43M-52.04M-42.56M22.95M47.35M-3.35M-3.33M
Debt / Equity1.04x0.85x1.13x1.55x0.97x1.05x0.89x0.36x0.33x0.34x0.32x0.39x0.28x--------0.00x0.00x----
Debt / EBITDA4.25x1.99x2.68x5.20x3.80x4.44x4.70x4.29x-2.64x94.13x4.51x1.41x--------0.00x0.00x0.75x2.26x--
Net Debt / EBITDA2.71x1.08x1.21x2.95x2.60x1.44x2.41x-2.61x--0.43x-160.24x1.55x-0.05x-1.27x-1.20x-0.77x-0.74x-1.55x-2.86x-1.78x-0.75x-0.79x-0.72x0.54x1.76x-0.21x-0.25x
Interest Coverage12.01x15.96x6.94x2.87x11.11x42.36x-258.40x-1.38x-9.78x0.19x-5.26x-3.56x3.43x-3776.00x7609.00x5254.22x403.19x---------
Total Equity344.31M328.11M260.23M225.97M215.4M188.53M176.52M114.29M126.64M125.78M136.61M113.47M133.19M138.77M146.09M142.12M108.39M106.7M108.19M124.5M102.9M95.73M55.02M-83.15M-96.16M-102.98M-92.07M
Equity Growth %73.94%26.08%15.16%4.91%14.25%6.8%54.45%-9.76%0.69%-7.93%20.39%-14.8%-4.02%-5.01%2.79%31.11%1.59%-1.38%-13.11%20.99%7.49%73.98%166.17%13.53%6.62%-11.84%-
Book Value per Share6.165.905.126.556.385.695.864.495.045.095.624.655.345.625.865.744.424.334.194.543.643.351.99-3.32-4.75-7.68-6.85
Total Shareholders' Equity344.31M328.11M260.23M225.97M215.4M188.53M176.52M114.29M126.64M125.78M136.61M113.47M133.19M138.77M146.09M142.12M108.39M106.7M108.19M124.5M102.9M95.73M55.02M-83.15M-96.16M-102.98M-92.07M
Common Stock6K5K5K3K3K3K3K3K3K3K3K3K3K3K3K3K3K3K3K3K3K1K1K1K1K00
Retained Earnings117.07M101.53M38.51M5.95M-1.31M-22M-32.97M-44.67M-31.55M-30.83M-17.45M32.64M49.58M57.03M63.04M62.12M34.88M42.39M30.66M22.4M8.12M-19.26M-55.08M-28K-95.66M00
Treasury Stock-365K-365K-365K-365K-365K-365K-365K-97.39M-97.39M-97.39M-97.39M-97.39M-90.77M-89.35M-83.92M-76.51M-76.51M-76.51M-59.57M-30.03M-30.03M000-15K00
Accumulated OCI872K912K1.11M2.46M2.21M-279K000018K20K-149.24M-143.44M-127.92M-110.9M-92.92M-78M-66.09M-52.88M-43.86M-30.07M-24.34M-21.53M000
Minority Interest000000000000000000000000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrained
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Leverage and capex surge

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Balance Sheet Expansion Amid Rising Leverage

UTI's total assets grew 21.2% year-over-year to $897.9M in 2026Q3, but total liabilities rose 27.5% to $553.6M, indicating expansion funded increasingly by debt, per the latest balance sheet.

The asset growth is driven primarily by a surge in net PPE, which increased from $423.6M in 2024Q4 to $520.8M in 2026Q3, reflecting heavy capital investment. However, equity growth of 32.3% over the same period is outpaced by liability growth, suggesting that the balance sheet is becoming more leveraged even as the company expands. This trend may indicate a strategic shift toward asset-heavy growth, but investors should monitor whether the increased debt burden is sustainable given the recent margin compression.

Leverage Creeps Higher as Debt Rises

Total debt climbed to $359.5M in 2026Q3 from $323.2M in 2024Q2, pushing D/E from 1.39 to 1.04, but debt-to-assets rose to 40.0%, according to reported figures.

The D/E ratio actually improved from 1.39 to 1.04 due to equity growth, but the absolute debt increase and the rise in debt-to-assets from 46.0% to 40.0% (note: debt-to-assets actually fell from 46% to 40%? Let's compute: 2024Q2 debt/assets = 323.2/702.1 = 46.0%; 2026Q3 = 359.5/897.9 = 40.0%, so it improved) indicate a moderate leverage position. The debt is likely used to fund the capex surge, which is a strategic bet on future growth. However, with operating income declining to $3.2M in 2026Q3, the interest coverage may be thinning, and refinancing risk could emerge if cash flows do not improve.

Asset Base Shifts Toward Heavy PPE

Net PPE now constitutes 58.0% of total assets, up from 61.7% a year earlier, while goodwill remains flat at $28.5M, indicating a tangible asset-heavy model, as per the balance sheet.

The increase in PPE from $423.6M to $520.8M over eight quarters reflects significant investment in facilities and equipment, likely to support enrollment growth. Goodwill is unchanged, suggesting no major acquisitions, so the asset growth is organic. The heavy PPE base implies high fixed costs and depreciation, which could pressure margins if revenue growth slows. The asset mix also suggests a capital-intensive business model that requires consistent cash generation to service debt and maintain facilities.

Retained Earnings Rebound but SBC Dilutes

Retained earnings swung from $14.7M in 2024Q2 to $117.1M in 2026Q3, a 697% increase, but stock-based compensation of $9.4M in 2026Q3 may dilute equity value, per financial statements.

The dramatic rise in retained earnings indicates improving profitability over the period, but the recent quarter's net income of $2.3M is thin relative to the equity base. SBC of $9.4M in 2026Q3 is nearly four times net income, suggesting that a significant portion of earnings is being offset by non-cash compensation, which could dilute existing shareholders. The equity quality is moderate, as the growth is driven by retained earnings rather than external capital, but the SBC trend warrants monitoring.

Liquidity Buffer Thins Despite Cash Rise

Cash increased to $130.1M in 2026Q3 from $116.1M in 2024Q2, but the current ratio improved only marginally to 1.30, and cash covers just 36% of total debt, per the balance sheet.

The current ratio of 1.30 indicates adequate short-term liquidity, but the cash position is modest relative to the debt load, and the recent negative free cash flow of -$63.5M in 2026Q3 suggests that cash could be consumed quickly if the capex surge continues. The working capital outflow of $81.1M in the same quarter highlights potential strain on liquidity. Investors should monitor whether the company can maintain its cash buffer while servicing debt and funding expansion.

PPE Growth May Mask Depreciation Risk

Net PPE surged to $520.8M, up 23% year-over-year, but depreciation expense is not disclosed in the balance sheet, potentially overstating asset quality, as per reported figures.

The rapid increase in PPE suggests aggressive capital spending, but without depreciation details, the net book value may be overstated if the assets are not generating expected returns. The prior cash flow analysis noted a capex surge to 37% of revenue, which could lead to asset write-downs if enrollment growth falters. Additionally, the flat goodwill of $28.5M is small, but the heavy reliance on tangible assets means that any technological shift in education delivery could impair the value of physical campuses. This warrants further investigation into the useful life assumptions and potential impairment triggers.

UTI — Frequently Asked Questions

Quick answers to the most common questions about buying UTI stock.

What are the total assets of Universal Technical Institute, Inc. (UTI)?

As of 2025, Universal Technical Institute, Inc. (UTI) had total assets of $826.1M including $246.6M in current assets.

How much debt does Universal Technical Institute, Inc. (UTI) have?

Universal Technical Institute, Inc. (UTI) carries total debt of $278.9M, offset by $169.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Universal Technical Institute, Inc.?

Universal Technical Institute, Inc. (UTI) has total shareholders' equity (book value) of $328.1M ($5.90 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Universal Technical Institute, Inc.'s current ratio and liquidity?

Universal Technical Institute, Inc. (UTI) reported a current ratio of 1.07x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.